523例初治成人急性白血病的疗效分析  

ANALYSIS OF THERAPEUTIC OF 523 ADULT ACUTE LEUKEMIA CASES WITHOUT PREVIOUS TREATMENT HISTORY

作　　者：董群生[1] 孟沛霖[1] 闵碧荷[1] 

机构地区：[1]第二军医大学附属长海医院

出　　处：《白血病》1997年第2期71-73,共3页

摘　　要：对５２３例成人初治急性白血病疗效进行了分析，结果发现成人急性白血病的完全缓解率、长期存活率与诱导期化疗方案的强度、年龄、白血病类型及髓外病变有关。庇护所的病变往往是白血病复发的根源，而目前普遍采用的髓内化疗及头颅放疗的措施对成人ＣＮＳＬ的防治效果不满意，更有效的治疗措施有待进一步探索。Seventy four adult patients with acute leukemia achieved long term survival and CR rate for over 3 years were reported. The result showed that the long term survival of the patients with acute leukemia was closely related with the intensification of induction chemotherapy, the FAB type of acute leukemia and the age of the patients. The shelter leukemia was the relapse source. We should improve the measures to prevent and treat the shelter leukemia.

关 键 词：急性 白血病 长期存活 药物疗法 

分 类 号：R733.710.5[医药卫生—肿瘤]